The MET protein stain that selects people with lung cancer for telisotuzumab vedotin.
Ventana Medical Systems' (Roche Tissue Diagnostics) MET (SP44) RxDx Assay was approved on 14 May 2025 (PMA P240037) as the companion diagnostic for telisotuzumab vedotin in non-small-cell lung cancer with high MET protein expression. It measures protein, not a MET gene change, so it selects a different group from tests for MET exon 14 skipping.
Immunohistochemistry with the SP44 antibody; the FDA list defines the selecting result as at least 50% of tumour cells with strong (3+) membrane and/or cytoplasmic staining. Connects to MET.
| Region | Year | Indication |
|---|---|---|
| US | 2025 | Companion diagnostic for telisotuzumab vedotin in NSCLC with MET protein overexpression |
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"VENTANA MET SP44 RxDx Assay" OR ABSTRACT:"VENTANA MET SP44 RxDx Assay" OR TITLE:"VENTANA MET" OR ABSTRACT:"VENTANA MET" OR TITLE:"SP44 RxDx Assay" OR ABSTRACT:"SP44 RxDx Assay") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about VENTANA MET (SP44) RxDx Assay, not a curated reading list.
Shares Companion diagnostic, Companion diagnostics, Immunohistochemistry (IHC), Histopathology & immunohistochemistry and the tag test.
Shares Companion diagnostic, Companion diagnostics, Immunohistochemistry (IHC), Histopathology & immunohistochemistry and the tag test.
Shares Companion diagnostic, Companion diagnostics, Immunohistochemistry (IHC), Histopathology & immunohistochemistry and the tag test.
Shares Companion diagnostic, Companion diagnostics, Immunohistochemistry (IHC), Histopathology & immunohistochemistry and the tag test.
Shares Companion diagnostic, Companion diagnostics, Immunohistochemistry (IHC), Histopathology & immunohistochemistry and the tag test.
Shares Companion diagnostic, Companion diagnostics, Immunohistochemistry (IHC), Histopathology & immunohistochemistry and the tag test.
Shares Companion diagnostics, Immunohistochemistry (IHC), Histopathology & immunohistochemistry, Roche / Genentech and the tag test.
Shares Companion diagnostic, Companion diagnostics, Immunohistochemistry (IHC), Histopathology & immunohistochemistry and the tag test.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/